A comparative study of oral terbinafine versus oral itraconazole daily versus oral terbinafine and itraconazole daily versus oral terbinafine and itraconazole pulses in tinea

Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Clinically suspected tinea corporis, tinea cruris or tinea faciei or any combination of these
•2. Confirmation of tinea by KOH microscopy
•Both criteria should be met.

•1. Pregnancy
•2. Lactation
•3. Presence of any other type of tinea e.g. onychomycosis
•4. Another skin disease at the site of tinea
•5. Inability to come for follow ups
•6. Intake of terbinafine or itraconazole in last 1 month
•7. History of drug reaction or allergy to terbinafine or itraconazole
•8. Present history of liver, renal or ischemic heart disease
•9. Patients on treatment with drugs that have interaction with terbinafine or itraconazole
•10. Patients requiring antihistamines due to co-existing skin disease e.g. urticaria
•11. Abnormal complete blood count (for hemoglobin value taken as abnormal will be <9 g/dl, for platelet count <1 lac/microliter), liver function tests, or renal function tests
•Any one criteria will exclude the patient.

发起方

Institute of Medical Sciences